Bausch Health's stock took a hit, closing down nearly 3% as investors reacted to recent developments.
Bausch Health Companies Inc (BHC.TO) experienced a decline in its stock price yesterday, closing at CA$9.06, down 2.79%. This drop comes amidst mixed news about the company's expansion efforts and ongoing challenges in profitability.
Investor takeaway: Investors should be cautious as Bausch Health navigates a challenging market, with its stock reflecting concerns about profitability and performance.
Advertisement
Bausch Health Companies Inc
BHC.TO
BHC.TO
Bausch Health Companies Inc
WealthAwesomeMarket cap
$3.39B
52W high
$11.08
52W low
$6.10
1W change
+3.07%
Beta
0.37
Analyst Price Targets
Based on analyst covering BHC
Wall Street analysts forecast BHC stock price to fall 22.6% over the next 12 months.
Consensus
BearishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$7.01
-22.6% Upside
Current Price
C$9.06
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BHC's historical volatility
30-Day Vol
96.1%
Annualized
90-Day Vol
66.9%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$10.83
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$9.62 | C$6.90 โ C$13.40 |
| 60 trading days | C$10.21 | C$6.39 โ C$16.31 |
| 90 trading days | C$10.83 | C$6.10 โ C$19.24 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Stock Down 2.79%
Bausch Health's market cap now stands at approximately CA$3.39 billion, reflecting investor apprehension.
Bull case
The companyโs recent collaborations, including its expansion into Mexico and EMEA markets with YUN, could improve its product offerings and market reach, potentially leading to future growth.
Bear case
Despite these expansion efforts, Bausch Health's ongoing negative profit margins and market volatility raise concerns about its ability to sustain growth and maintain investor confidence.
Market Reaction to Expansion News
Advertisement
Bausch Health's announcement about expanding its collaboration with YUN into Mexico and several EMEA markets aimed to enhance its dermatology portfolio. However, the market's reaction was lukewarm, showing skepticism about the immediate impact of these expansions on profitability. Investors are likely weighing the long-term benefits against the current financial instability.
Profitability Concerns Persist
Despite strategic growth initiatives, Bausch Health continues to grapple with a negative profit margin of -10.12%. This ongoing challenge raises questions about the company's ability to turn its expansion efforts into real financial success, contributing to the stock's decline yesterday.
Investor Sentiment and Market Outlook
With a market cap of CA$3.39 billion, Bausch Health's stock performance reflects broader investor sentiment about the healthcare sector's volatility. As the company pursues growth strategies, investors will closely monitor its financial health and market responses to gauge future performance.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile โโ Reviewed by Certified Financial Professionals
This content has been reviewed by CFAยฎ charterholders and Certified Financial Planners (CFPยฎ) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFAยฎ charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFPยฎ professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
โ ๏ธ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
